Skip to content
Tuesday, November 10, 2026
Alpha Spin Market

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Agreement Due to Data Fears

Medical aid illustration
The proposed US financial assistance was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a major US health deal valued at 367 million US dollars (£272m) spanning five years because of the United States' request for confidential biological samples.

This move came to light following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government spokesperson later stated that the US was demanding access to genetic material for research and commercial purposes while refused to guarantee the benefits from future medical innovations.

"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had provided over $1.9bn in health funding to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has called for further dialogue to reach a deal suitable to all parties so the nation's critical HIV programme can continue.

Broader Context

This development follows a comparable case in Kenya, where a court suspended a related deal with the US after concerns were raised about the security of Kenyans' medical information.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and accountability.

According to reports, Sixteen nations in Africa have to date signed these new health pacts, representing more than $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via US-supported programmes," Tremont commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.

"Put simply, our nation would supply the raw materials for scientific discovery without any assurance that the end products would be available to our people if a new pandemic arise."

National Interest and International Frameworks

He also noted that the US's withdrawal from the global health body and its push of bilateral deals were disrupting systems already set up through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential pandemics.

"This mechanism is designed to guarantee that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."

These objections over the US deal "are not meant as opposition to America," he added.

"We welcome further dialogue with our US partners on how subsequent co-operation might be arranged in a manner that respects the sovereignty and interests of each country."

Health Experts Response

Medical experts expressed it understood the government's concerns, but suggested that talks need to persist considering much of the nation's Aids initiatives were funded by external financing.

"Where technical issues exist, including those relating to information security or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," it said.

This impasse emphasises the complex challenges between receiving much-needed international aid and protecting national sovereignty in an increasingly interconnected world.

The writer

Michael Smith

Lena Vance is a tech journalist and market analyst with over a decade of experience covering emerging technologies and consumer electronics.

Alpha Spin Market

Type to search articles.